Tobacco News and Research

RSS

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

The U.S. Food and Drug Administration today approved Vonvendi, von Willebrand factor (Recombinant), for use in adults 18 years of age and older who have von Willebrand disease (VWD). Vonvendi is the first FDA-approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with VWD.

8 Dec 2015

Kanuma approved as first treatment for patients with LAL deficiency

Today, the U.S. Food and Drug Administration approved Kanuma (sebelipase alfa) as the first treatment for patients with a rare disease known as lysosomal acid lipase (LAL) deficiency.

8 Dec 2015

FDA clears use of XSTAT 30 wound dressing to control severe bleeding in civilian population

Today, the U.S. Food and Drug Administration cleared the use of the XSTAT 30 wound dressing, an expandable, multi-sponge dressing used to control severe, life-threatening bleeding from wounds in areas that a tourniquet cannot be placed (such as the groin or armpit) in battlefield and civilian trauma settings.

8 Dec 2015

$Cadmium exposure increases risk of osteoporosis and fractures$

Cadmium exposure increases risk of osteoporosis and fractures

People who are exposed to higher levels of cadmium have an increased risk of osteoporosis and fractures. Cadmium also affects the kidneys. A doctoral thesis at Sahlgrenska Academy explored this issue in a study of over 900 older men.

7 Dec 2015

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.

30 Nov 2015

Australian Government still refuses to admit failure of tobacco branding ban

On the third anniversary of Australia's controversial 'plain' packaging legislation for tobacco products, the Government is still refusing to admit its failure. This would explain why the Department of Health (DoH) is pushing back the publication of its Post-Implementation Review (PIR).

30 Nov 2015

Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

A large population-based study has confirmed the association between the presence of human papillomavirus DNA in oropharyngeal squamous cell cancer and improved patient survival.

27 Nov 2015

First seasonal influenza vaccine containing adjuvant now approved by FDA

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.

25 Nov 2015

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) who have not previously received medication specifically for treating their advanced lung cancer.

24 Nov 2015

BioThrax approved to prevent disease after exposure to anthrax spores

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

Hiding cigarettes at convenience stores significantly reduces teenagers' smoking risk

Keeping tobacco products out of view in convenience stores significantly reduces teenagers' susceptibility to future cigarette use compared to when tobacco advertising and products are visible, according to a new RAND Corporation study.

23 Nov 2015

Study shows significant decline in retailer compliance with NYC's new tobacco law

In a study examining compliance with New York City's new law that raised the legal age for purchasing cigarettes to 21 years of age, researchers with New York University and University of California, Los Angeles found that compliance with identification (ID) checks has significantly decreased since the law was made effective.

23 Nov 2015

Mason researchers patent new breast cancer treatment

George Mason University researchers have patented a new breast cancer treatment that uses a common malaria drug to stop cancer in its beginning stages.

21 Nov 2015

Exposure to e-cigarette ads may boost usage among young adults

Exposure to e-cigarette advertisements may enhance curiosity and usage among young adults, according to a study published this week in the journal Nicotine & Tobacco Research.

21 Nov 2015

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Today the U.S. Food and Drug Administration granted approval for Ninlaro (ixazomib) in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.

21 Nov 2015

Smoking rates remain alarmingly high among American Indians, LGBT smokers and people with mental health issues

While the overall number of people who smoke in the United States is at an all-time low, not everyone is quite ready to celebrate. "We're making great strides, but it's evident that there are large groups of people who continue to struggle with tobacco and the chronic diseases associated with it," said Amy Lukowski, Psy.D., clinical director of Health Initiatives at National Jewish Health in Denver and for its QuitLogix program, the largest non-profit smoking quitline in the country.

20 Nov 2015

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

VolitionRx Limited today announced interim data demonstrating its NuQ blood tests have accurately detected more than 90% of lung cancer cases in a study of 73 patients.

19 Nov 2015

U.S. adults who use smokeless tobacco products have higher levels of nicotine, carcinogen

U.S. adults who used only smokeless tobacco products had higher levels of biomarkers of exposure to nicotine and a cancer-causing toxicant -- the tobacco-specific nitrosamine NNK -- compared with those who used only cigarettes

19 Nov 2015

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Women & Infants Hospital of Rhode Island, a Care New England hospital, announced today that it has been recognized as a 2014 Top Performer on Key Quality Measures by The Joint Commission, the leading accreditor of health care organizations in the U.S.

19 Nov 2015

Tobacco News and Research

FDA approves recombinant von Willebrand factor for treating bleeding episodes in adults with VWD

Kanuma approved as first treatment for patients with LAL deficiency

FDA clears use of XSTAT 30 wound dressing to control severe bleeding in civilian population

Cadmium exposure increases risk of osteoporosis and fractures

FDA grants approval for Empliciti (elotuzumab) to treat patients with multiple myeloma

Australian Government still refuses to admit failure of tobacco branding ban

Improved Survival In HPV-Positive Oropharyngeal Cancer Patients Confirmed

First seasonal influenza vaccine containing adjuvant now approved by FDA

Portrazza approved to treat patients with advanced squamous non-small cell lung cancer

BioThrax approved to prevent disease after exposure to anthrax spores

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

Hiding cigarettes at convenience stores significantly reduces teenagers' smoking risk

Study shows significant decline in retailer compliance with NYC's new tobacco law

Mason researchers patent new breast cancer treatment

Exposure to e-cigarette ads may boost usage among young adults

Ninlaro (ixazomib) approved to treat people with multiple myeloma

Smoking rates remain alarmingly high among American Indians, LGBT smokers and people with mental health issues

VolitionRx's NuQ blood tests accurately detect more than 90% of lung cancer cases

U.S. adults who use smokeless tobacco products have higher levels of nicotine, carcinogen

Women & Infants Hospital recognized as 2014 Top Performer on Key Quality Measures

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News